Anna Sofie Kappel Buhl

6PUBLICATIONS
28CO-AUTHORS
PharmacogenomicsHaematological tumoursGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 22, 2026
Comparing the Predictive Performance of Machine Learning Models with a Newly Developed Population Pharmacokinetic Model for Busulfan in Paediatric Patients.

|Jun 18, 2026
Central nervous system penetration of imatinib in acute lymphoblastic leukemia: Pharmacokinetic analysis and clinical implications.

|May 28, 2026
Pharmacokinetic profiling of imatinib in relation to CYP3A4 activity in leukaemia patients.

|Sep 08, 2025
Published Population Pharmacokinetic Models of Imatinib Perform Poorly on TDM Data from Pediatric Patients.

Tianwu Yang, Anna Sofie Buhl Rasmussen, Allan Weimann

|Jul 16, 2025
DNA-incorporated thioguanine to detect potential non-adherence to maintenance therapy in acute lymphoblastic leukemia.

Mathilde Rønne Koch, Anna Sofie Buhl Rasmussen, Bodil Als-Nielsen

|Aug 13, 2018
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study.

Anna Sofie Kappel Buhl, Troels Dreier Christensen, Ib Jarle Christensen

Pageof 1

Frequent Collaborators

5 joint publications

Maria Thastrup

5 joint publications

Kjeld Schmiegelow

4 joint publications

Trine Meldgaard Lund

4 joint publications

Tianwu Yang